Notice to Extraordinary General Meeting in BioInvent International AB

LUND, SE / ACCESSWIRE / June 16, 2022 / BioInvent Worldwide (STO:BINV)

The shareholders of BioInvent Worldwide AB (publ), Reg. No 556537-7263, are hereby invited to attend the Extraordinary Common Assembly (the “EGM”) to be held on Tuesday 12 July 2022. The EGM shall be held solely by advance voting (postal voting) in accordance with momentary laws.

A. NOTICE OF ATTENDANCE

Shareholders who want to attend the EGM should:

(i) be recorded within the share register maintained by Euroclear Sweden AB (“Euroclear“), as of Monday 4 July 2022; and

(ii) notify the corporate of their intention to take part within the EGM no later than Monday 11 July 2022, by submitting their advance votes in accordance with the directions underneath the heading “Advance voting” beneath, in order that the advance vote is obtained by BioInvent no later than that day.

Shareholders whose shares are nominee-registered should briefly re-register their shares in their very own title within the shareholders’ register maintained by Euroclear with a view to take part within the EGM (so referred to as “voting rights registration”). The shareholders’ registers as of the report date on 4 July 2022 will embrace voting rights registrations made not later than 6 July 2022. Subsequently, shareholders should, in accordance with the respective nominee’s routines, in due time earlier than stated date request their nominee to hold out such voting rights registration.

Advance voting
The shareholders might train their voting rights on the EGM solely by voting upfront, so referred to as postal voting in accordance with Part 20 of the Act (2022:121) on momentary exceptions to facilitate the execution of normal conferences in firms and different associations.

A particular type shall be used for advance voting. The shape is offered on the corporate’s web site, www.bioinvent.se. The advance voting type is taken into account because the notification of participation on the EGM.

The finished and signed voting type should be obtained by BioInvent no later than Monday 11 July 2022, kindly earlier than 4.00 pm. CEST. The finished and signed type shall be despatched to BioInvent by e-mail to [email protected] or by common mail to BioInvent Worldwide AB, Ideongatan 1, SE-223 70 Lund, Sweden, att: Stefan Ericsson. If the shareholder votes upfront by proxy, an influence of lawyer shall be enclosed with the shape. Proxy type is offered upon request and on the corporate’s web site www.bioinvent.se. If the shareholder is a authorized entity, a duplicate of the registration certificates or, if such doc doesn’t exist, the same doc of authorization is to be connected. The shareholder might not present the postal vote with particular directions or situations. In that case, your entire vote is invalid.

Additional directions and situations are included within the type for advance voting.

B. SHAREHOLDERS’ RIGHT TO REQUEST INFORMATION

The Board of Administrators and the managing director shall, if any shareholder so requests, and if the Board of Administrators considers that this may be carried out with out important hurt for the corporate, give data on circumstances that may have an effect on the judgement of an merchandise on the agenda. Requests for such data shall be made in writing to BioInvent Worldwide AB, Ideongatan 1, SE-223 70 Lund, Sweden, att: Stefan Ericsson or by e-mail to [email protected], no later than ten days earlier than the EGM, i.e. no later than Saturday 2 July 2022. The knowledge shall be disclosed by being held obtainable at BioInvent Worldwide AB, Ideongatan 1, SE-223 70 Lund, Sweden, and on the corporate’s web site, www.bioinvent.se, no later than 5 days earlier than the EGM, i.e. no later than Thursday 7 July 2022. The knowledge may also be distributed to the shareholders who so requests and state their postal deal with or e-mail deal with.

C. AGENDA FOR THE MEETING

Proposal for agenda

1. Election of Chairman of the assembly
2. Election of individual to approve the minutes
3. Preparation and approval of the voting checklist
4. Dedication of compliance with the principles of convocation
5. Approval of the agenda
6. Institution of the variety of members of the Board of Administrators
7. Institution of charges for members of the Board of Administrators
8. Election of recent members of the Board of Administrators
(a) Nanna Lüneborg
(b) Natalie Berner

Proposals concerning gadgets on the agenda

Election of Chairman of the assembly (merchandise 1)

The Board of Administrators proposes that Board secretary and lawyer Madeleine Rydberger or, within the occasion she is prevented from attending, the individual as a substitute designated by the Board of Administrators, shall be Chairman of the assembly.

Election of individual to approve the minutes (merchandise 2)

It’s proposed that Erik Esveld, representing Van Herk Investments B.V., or if he’s prevented from attending, the individual as a substitute designated by the Board of Administrators, is assigned to approve the minutes of the EGM along with the Chairman. The project to approve the minutes additionally consists of verifying the voting checklist and that the advance votes obtained are accurately acknowledged within the minutes of the EGM.

Preparation and approval of the voting checklist (merchandise 3)

The voting checklist proposed to be authorised is the voting checklist ready by the corporate, based mostly on the shareholders’ register for the EGM ready by Euroclear Sweden AB and the advance votes obtained, as verified and advisable by the individual elected to approve the minutes.

Dedication of compliance with the principles of convocation (merchandise 4)

It’s proposed that the EGM has been duly convened as authorised by the Chairman of the assembly, based mostly on the Swedish Corporations Act’s and the Articles of Affiliation’s provisions concerning discover to attend Extraordinary Common Conferences.

Approval of the agenda (merchandise 5)

It’s proposed that the agenda included within the discover needs to be authorised.

Elections and charges (gadgets 6-8)

The Nomination Committee, consisting of Laura Feinleib (Redmile Group, LLC), Erik Esveld (Van Herk Investments B.V.), Vincent Ossipow (Omega Funds, LP), and Leonard Kruimer (Chairman of the Board), has knowledgeable the corporate of the next proposals.

The Board of Administrators shall be elevated by two Board members and thereafter include eight members elected by the overall assembly.New election of Nanna Lüneborg and Natalie Berner as Board members for the interval till the top of the following Annual Common Assembly. Details about the candidates proposed for brand spanking new election is introduced in a separate press launch.The annual charges per Board member (together with charges for committee work), as resolved by the Annual Common Assembly on 28 April 2022, shall proceed to use entailing a sure improve of the whole charges for the reason that variety of Board members is elevated by two. Charges (together with charges for committee work) are to be paid to incoming Board members professional rata in relation to the Board member’s precise responsibility interval in comparison with the entire interval from the Annual Common Assembly 2022 till the top of the following Annual Common Assembly.

D. AVAILABLE DOCUMENTS ETC

Proxy kinds and advance voting type can be found on the firm’s web site, www.bioinvent.se. Different paperwork to be held obtainable in accordance with the Swedish Corporations Act, shall be obtainable on the corporate’s web site as from Tuesday 21 June 2022, on the newest, and be distributed to shareholders who so request and state their postal deal with.

On the time of this discover, the whole variety of shares and votes within the firm quantities to 58,471,096.

E. PROCESSING OF PERSONAL DATA

For data on how your private knowledge is processed, see https://www.euroclear.com/dam/ESw/Authorized/Privateness-notice-bolagsstammor-engelska.pdf.

_________________________

Lund in June 2022
The Board of Administrators
BIOINVENT INTERNATIONAL AB (publ)

About BioInvent
BioInvent Worldwide AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech firm that discovers and develops novel and first-in-class immuno-modulatory antibodies for most cancers remedy, with presently three drug candidates in 4 ongoing medical applications in Part 1/2 trials for the therapy of hematological most cancers and strong tumors, respectively and a fifth program simply initiating medical growth. The Firm’s validated, proprietary F.I.R.S.T™ expertise platform concurrently identifies each targets and the antibodies that bind to them, producing many promising new drug candidates to gasoline the Firm’s personal medical growth pipeline or for added licensing and partnering.

The Firm generates revenues from analysis collaborations and license agreements with a number of top-tier pharmaceutical firms, in addition to from producing antibodies for third events within the Firm’s totally built-in manufacturing unit. Extra data is offered at www.bioinvent.com. Observe on Twitter: @BioInvent.

BioInvent Worldwide AB (publ)
Co. Reg. No. Org nr: 556537-7263
Visiting deal with: Ideongatan 1
Mailing deal with: 223 70 LUND
Cellphone: +46 (0)46 286 85 50
www.bioinvent.com

Attachments

Discover to Extraordinary Common Assembly in BioInvent Worldwide AB

SOURCE: BioInvent Worldwide

View supply model on accesswire.com:
https://www.accesswire.com/705362/Discover-to-Extraordinary-Common-Assembly-in-BioInvent-Worldwide-AB